There is no single universally agreed dose of L-methylfolate for people with MTHFR variants, because the right amount depends on which variant you carry, whether you’re homozygous or heterozygous, and why you’re taking it. In clinical practice, prescribed doses range from as low as 400 micrograms per day for general folate support up to 15 milligrams per day for treatment-resistant depression. That forty-fold spread reflects genuinely different clinical situations, not just uncertainty, and understanding where you fall in that range matters.
Why MTHFR Variants Affect Your Folate Needs
Your body needs folate in its active form, 5-methyltetrahydrofolate (5-MTHF), to do its work. When you eat food containing natural folate or take folic acid supplements, your body has to convert those forms into 5-MTHF through a series of enzymatic steps. The MTHFR enzyme handles a critical step in that conversion. If you carry certain variants in the MTHFR gene, that enzyme works less efficiently, which means less of the folate you consume ends up in its usable form.
The two most studied variants are C677T and A1298C. Having one copy of C677T (heterozygous) reduces enzyme activity moderately. Having two copies (homozygous) reduces it more substantially. A1298C has a milder effect. Some people carry one copy of each, known as compound heterozygous, which also reduces activity. The practical consequence is that people with these variants may not get enough active folate from standard folic acid supplementation alone, and L-methylfolate, which is already in the active form, bypasses the bottleneck entirely.
When the MTHFR enzyme underperforms, one downstream effect is that homocysteine can accumulate in the blood. Homocysteine is normally recycled back into methionine using folate and vitamin B12 as helpers, so inadequate active folate disrupts that recycling process and allows homocysteine to build up.
What Clinicians Actually Prescribe by Genotype
A case series examining folate prescriptions for patients with confirmed MTHFR polymorphisms gives us a window into real-world dosing patterns. Patients with a heterozygous A1298C variant received between 500 and 1,400 micrograms of L-methylfolate daily. Those with a heterozygous C677T variant were prescribed a wider range, from 500 to 3,800 micrograms, with an average of about 2,850 micrograms per day. The single patient in the study with homozygous C677T received 3,500 micrograms of L-methylfolate along with 700 micrograms of folinic acid. Patients who were compound heterozygous (one copy of each variant) were prescribed between 1,500 and 3,800 micrograms, averaging about 2,400 micrograms per day.1PubMed Central. Variations in folate prescriptions for patients with the MTHFR genetic polymorphisms: A case series study
A few things stand out from those numbers. First, the C677T variant consistently warrants higher doses than A1298C, which makes sense given its larger impact on enzyme activity. Second, even within the same genotype, there’s wide variation in what different clinicians prescribe. This reflects the absence of rigid dosing guidelines from major medical bodies and the reality that clinicians adjust based on lab results, symptoms, and individual response. Third, the doses tend to cluster well above the general population’s recommended daily intake of folate, which sits around 400 micrograms of dietary folate equivalents for most non-pregnant adults.
Higher Doses for Depression
The highest doses of L-methylfolate in clinical use are prescribed not for folate deficiency per se, but as an add-on treatment for depression that hasn’t responded to antidepressants alone. Two randomized, double-blind trials tested 15 milligrams per day of L-methylfolate as adjunctive therapy in patients with major depression who had not responded adequately to SSRIs. The first trial, using 7.5 mg per day, did not show a clear benefit over placebo. The second trial, at 15 mg per day, showed significantly greater improvement in both response rates and symptom scores. The number needed to treat for response was about six, meaning roughly one in six patients improved specifically because of the L-methylfolate.2PubMed. L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials
A 12-month open-label follow-up of patients taking 15 mg per day of L-methylfolate alongside an SSRI found no serious adverse events, and no one left the study because of a side effect.3The Journal of Clinical Psychiatry. Long-Term Efficacy, Safety, and Tolerability of l-Methylfolate Calcium 15 mg as Adjunctive Therapy With Selective Serotonin Reuptake Inhibitors That 15 mg dose has become the standard for this psychiatric application, and it’s worth noting that it’s roughly five to thirty times the doses used for general MTHFR-related folate support. This is not a dose most people need to take for nutritional adequacy.
A small case series also looked at L-methylfolate augmentation in adolescents with treatment-resistant depression. Ten patients, most of whom had at least one MTHFR variant, showed improvement in depression, anxiety, and irritability, and the treatment was well tolerated.4PubMed. L-methylfolate Augmentation to Antidepressants for Adolescents with Treatment-Resistant Depression: A Case Series The evidence here is limited to case-level data, but it suggests that clinicians are using similar strategies in younger patients.
Why L-Methylfolate Instead of Folic Acid
Folic acid is the synthetic form of folate found in most supplements and fortified foods. It has no biological activity on its own and must be converted through several enzymatic steps before your body can use it.5Georgetown Medical Review. The Critical Role of Folate in Prenatal Health and a Proposed Shift from Folic Acid to 5-Methyltetrahydrofolate Supplementation L-methylfolate, by contrast, is the finished product: it’s available for use right after you swallow it. A randomized crossover study comparing a single dose of L-methylfolate to folic acid found that L-methylfolate delivered about 1.6 times more total folate into the bloodstream, with roughly 2.5 times more of the active 5-MTHF form specifically. It also reached peak blood levels faster, in about 50 minutes versus nearly two hours for folic acid.6PubMed Central. Pharmacokinetics of (6S)-5-Methyltetrahydrofolate dicholine salt compared to folic acid: a randomized double-blind single dose cross-over study
For people with normally functioning MTHFR enzymes, folic acid works well enough. But for those with reduced enzyme activity, folic acid can pile up in its unmetabolized form (UMFA) because the conversion pathway is sluggish. UMFA accumulation has been linked to masking of vitamin B12 deficiency, and some research has associated it with cognitive and psychiatric concerns, though the strength of that evidence varies.7PubMed Central. Adverse Effects of Excessive Folic Acid Consumption and Its Implications for Individuals With the Methylenetetrahydrofolate Reductase C677T Genotype The C677T variant in particular has been associated with higher levels of UMFA even in breast milk among women who carry it.8PubMed Central. The MTHFR 677C>T polymorphism is associated with unmetabolized folic acid in breast milk in a cohort of Canadian women Switching to L-methylfolate sidesteps this conversion issue entirely.
Pregnancy, MTHFR, and Folate Dosing
Folate needs increase during pregnancy because it’s essential for fetal neural development. Standard prenatal recommendations call for 400 to 800 micrograms of supplemental folic acid per day, with the upper intake level for folic acid set at 1,000 micrograms for all adults.9Advances in Nutrition. Perspective: Time to Resolve Confusion on Folate Amounts, Units, and Forms in Prenatal Supplements But those guidelines were built around folic acid, not L-methylfolate. And that upper limit was established specifically for folic acid out of concern for masking B12 deficiency, a concern that doesn’t apply in the same way to methylfolate.
For pregnant women with MTHFR variants, clinicians sometimes prescribe substantially more. A case series of women with epilepsy and confirmed MTHFR mutations who were given methylated folate during pregnancy used doses ranging from 5 to 15 milligrams of L-methylfolate daily alongside methylcobalamin (a form of vitamin B12) and prenatal vitamins. All had uncomplicated pregnancies.10PubMed Central. Pregnancy outcomes in women with epilepsy and MTHFR mutations supplemented with methylated folate and methylcobalamin (methylated B12) This is a tiny sample and not generalizable on its own, but it illustrates the range of doses that specialists are comfortable prescribing during pregnancy in higher-risk situations.
Vitamin B12 is a critical partner to folate in pregnancy. The two nutrients share overlapping metabolic pathways, and B12 status can modify how effectively folate works. A review of the evidence emphasized that MTHFR genetic polymorphisms and vitamin B12 levels are both important modifiers of folate metabolism’s relationship with pregnancy outcomes, and that no optimal threshold for circulating folate has been established to balance benefits and risks across all pregnancy complications.11PubMed Central. The roles of folate, MTHFR genetics, vitamin B12 in pregnancy outcomes If you’re pregnant and have an MTHFR variant, your clinician will likely want to check both your folate and B12 levels to guide dosing.
B12 and Other Cofactors You Should Not Ignore
L-methylfolate doesn’t work in isolation. The reaction that converts homocysteine back into methionine requires vitamin B12 as a cofactor. If your B12 is low, pumping in more methylfolate may not fix elevated homocysteine. A pilot study in patients with diabetes used a combination supplement containing 900 micrograms of L-methylfolate plus methylcobalamin and other micronutrients. After three months, plasma homocysteine dropped by an average of about 32%.12PubMed Central. A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes The combination nature of the supplement makes it hard to credit any single ingredient, but it’s consistent with the broader understanding that folate and B12 are metabolic partners.
A separate trial tested 400 micrograms per day of L-methylfolate alone in adults with elevated homocysteine and MTHFR polymorphisms. After three months, homocysteine levels dropped significantly.13Clinical Nutrition ESPEN. Efficacy of folinic acid versus l-methylfolate on total homocysteine-lowering treatments in healthy Greek adults with hyperhomocysteinemia and MTHFR gene polymorphisms That’s a relatively modest dose delivering measurable biochemical improvement, which suggests that for people whose primary goal is normalizing homocysteine, high-dose supplementation isn’t always necessary. The practical takeaway: check B12 alongside folate, and don’t assume that more methylfolate alone will solve the problem if B12 is also low.
Safety at Various Doses
One of L-methylfolate’s practical advantages is its safety profile. Because it doesn’t carry the same B12-masking concern as folic acid, the standard upper intake limit of 1,000 micrograms for folic acid does not directly apply to it, though no separate upper limit has been formally established by regulatory bodies. A systematic review of folate-form safety noted that in animal studies, L-methylfolate showed no toxicity even at extraordinarily high doses. In human clinical studies, people taking L-methylfolate at doses from 400 micrograms to 15 milligrams daily for periods up to 12 months reported no more adverse effects than those taking a placebo.14Biomedicine & Pharmacotherapy. The potential use of folate and its derivatives in treating psychiatric disorders: A systematic review
That said, “safe and well tolerated in studies” doesn’t mean you should freelance with doses. Some people report headaches, irritability, or insomnia when starting methylfolate, particularly at higher doses. These reports are largely anecdotal and not well documented in the trial literature, where adverse event rates haven’t differed from placebo, but they show up frequently enough in patient communities to be worth mentioning. If you experience these, a lower starting dose with a gradual increase is a reasonable approach. And if you’re taking psychiatric medications, the interaction between methylfolate and neurotransmitter pathways is the whole point of its use in depression, so discuss dosing with whoever manages those prescriptions.
Testing That Actually Matters
There’s been a boom in consumer genetic testing that flags MTHFR variants, and this has driven a lot of people to seek out L-methylfolate supplementation. But knowing your MTHFR genotype doesn’t actually tell you whether you have a functional folate problem. Many people with MTHFR variants have perfectly normal folate and homocysteine levels, especially if their diet is folate-rich. Current clinical guidance recommends assessing fasting plasma homocysteine, serum folate, and red blood cell folate levels to evaluate whether someone actually has a functional deficiency, rather than relying on MTHFR genetic testing alone.15PubMed Central. MTHFR genetic testing: is there a clinical utility?
This is an important point because it changes how you should think about dosing. If your homocysteine is normal and your folate levels are healthy, an MTHFR variant on a genetic test doesn’t mean you need megadose supplementation. Conversely, if your homocysteine is elevated and your folate is low, you have a concrete target to treat regardless of whether you’ve been genotyped. The genotype can inform which form of folate to use (methylfolate rather than folic acid), but the lab values are what determine whether supplementation is needed and help calibrate the dose.
Different Supplement Forms on the Market
Walk through a supplement aisle or browse online and you’ll encounter L-methylfolate sold under several chemical names: Metafolin (calcium L-methylfolate), Quatrefolic (glucosamine salt of 5-MTHF), and various generic versions. The European Food Safety Authority evaluated whether these different salt forms affect bioavailability and concluded that the influence of the attached cation (calcium versus glucosamine) on bioavailability is likely within the margin of error.16PubMed Central. Conversion of calcium-l-methylfolate and (6S)-5-methyltetrahydrofolic acid glucosamine salt into dietary folate equivalents In practical terms, you don’t need to worry much about which salt form your supplement uses.
What does matter is the stereochemistry. The biologically active form is the (6S) isomer. Some cheaper supplements contain a racemic mix of (6S) and (6R) forms, where the (6R) half has no biological activity. If a label says “L-methylfolate” or “L-5-MTHF” without specifying (6S), look for additional labeling or certifications. A supplement listing 1,000 micrograms of racemic methylfolate delivers only about 500 micrograms of the active form.
Your Gut Bacteria Make Folate Too, But Don’t Count on It
About half of the bacterial genomes found in the human gut have at least some genetic capacity to produce folate, and roughly 13% have the complete machinery for it.17PubMed Central. Microbial Metabolic Capacity for Intestinal Folate Production and Modulation of Host Folate Receptors That sounds like a promising backup supply, but an observational study of 200 adults found that the gut bacteria’s folate-producing potential in culture conditions did not predict actual serum folate levels or plasma homocysteine in those same people.18Food Research International. Ex vivo folate production by fecal bacteria does not predict human blood folate status: Associations between dietary patterns, gut microbiota, and folate metabolism The folate that gut bacteria make may be consumed by other bacteria, may not be well absorbed in the colon where most of it is produced, or may simply be too small in quantity to move the needle. For now, you can’t supplement less and hope your microbiome picks up the slack.
Putting the Doses in Context
If you’ve come away from this feeling like the dosing landscape is scattered, that’s because it genuinely is. Here’s a rough map of where different doses fit:
- 400-800 μg: General folate support, roughly equivalent to standard prenatal or daily supplement levels. Appropriate for mild MTHFR variants (like heterozygous A1298C) with normal or borderline lab values. A study of adults with MTHFR polymorphisms showed that even 400 μg per day of L-methylfolate lowered homocysteine over three months.
- 1-4 mg: The range most commonly prescribed for people with heterozygous or compound heterozygous MTHFR variants and confirmed folate-related lab abnormalities. This is the clinical bread-and-butter zone for MTHFR-specific supplementation.
- 5-15 mg: Reserved for specific clinical scenarios: treatment-resistant depression as an add-on to antidepressants, high-risk pregnancy with MTHFR variants, or persistently elevated homocysteine that hasn’t responded to lower doses. These amounts are typically prescribed and monitored by a clinician.
The absence of formal dosing guidelines from bodies like the FDA or professional medical societies means that most of these decisions happen at the individual clinician level, guided by lab results and clinical response rather than a standardized algorithm. If your homocysteine normalizes on 1 milligram, there’s no established reason to take 5. If it stays stubbornly high, there may be cause to increase, but your clinician should also be checking B12 and considering other possible contributors before simply escalating the methylfolate dose.